Successful Management of Ibrutinib-Induced Thrombocytopenia with Eltrombopag in a Patient with Waldenstr�m Macroglobulinemia

Successful Management of Ibrutinib-Induced Thrombocytopenia with Eltrombopag in a Patient with Waldenstr�m Macroglobulinemia [Turk J Hematol]

Turk J Hematol. 2022; 39(4): 275-276 | DOI: 10.4274/tjh.galenos.2022.2022.0397

Successful Management of Ibrutinib-Induced Thrombocytopenia with Eltrombopag in a Patient with Waldenstr�m Macroglobulinemia

Abdulkadir Er�al��kan¹, Fatma Zehra Avc�², Ahmet Emre E�kazan³
¹D�zce Atat�rk State Hospital, Department of Internal Medicine, Division of Hematology, D�zce, Turkey
²�stanbul University-Cerrahpa�a, Cerrahpa�a Faculty of Medicine, Department of Internal Medicine, �stanbul, Turkey
³�stanbul University-Cerrahpa�a, Cerrahpa�a Faculty of Medicine, Department of Internal Medicine, Division of Hematology, �stanbul, Turkey

Keywords: Eltrombopag, Ibrutinib, Thrombocytopenia, Toxicity, Waldenstr�m macroglobulinemia

Waldenstr�m Makroglobulinemisi Olan Bir Hastada �brutinib ile �li�kili Trombositopeninin Eltrombopag ile Ba�ar�l� Y�netimi

Anahtar Kelimeler: Eltrombopag, �brutinib, Trombositopeni, Toksisite, Waldenstr�m makroglobulinemisi

Abdulkadir Er�al��kan, Fatma Zehra Avc�, Ahmet Emre E�kazan. Successful Management of Ibrutinib-Induced Thrombocytopenia with Eltrombopag in a Patient with Waldenstr�m Macroglobulinemia. Turk J Hematol. 2022; 39(4): 275-276

Corresponding Author: Ahmet Emre E�kazan

TOOLS

Full Text PDF

Download citation

RIS

EndNote

BibTex

Medlars

Procite

Reference Manager

Share with email

Similar articles

PubMed

Google Scholar

In authors and institutes

In titles and abstracts

In keywords

In all


	E-ISSN: 1308-5263
Archive Most Accessed Articles Most Cited Articles Aims and Scope Instructions For Authors Editorial Board Advisory Board Manuscript Submission Why to Submit Search Contact